Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com//news-release/2024/03/06/2841460/0/en/Bioxytran-Announces-Preprint-of-Shingles-Case-Study-Showing-Clearance-Using-a-Topical-Galectin-3-Antagonist.html
https://www.globenewswire.com//news-release/2024/02/21/2832724/0/en/Bioxytran-s-Oral-Antiviral-Drug-to-Enter-Dose-Optimization-Clinical-Trial-for-COVID-19.html
https://www.globenewswire.com//news-release/2023/10/04/2754626/0/en/Bioxytran-Interview-at-the-Emerging-Growth-Conference.html
https://www.globenewswire.com//news-release/2023/09/14/2743381/0/en/Bioxytran-Announces-Broad-Spectrum-Antiviral-Activity-Highlighted-in-ProLectin-M.html
https://www.globenewswire.com//news-release/2023/08/24/2731222/0/en/Bioxytran-Announces-FDA-Clearance-of-its-IND-Application-for-ProLectin-M-in-Clinical-Trials.html
https://www.globenewswire.com/news-release/2023/08/08/2720451/0/en/Bioxytran-Initiates-a-Registrational-Trial-of-Oral-ProLectin-M-for-Mild-to-Moderate-COVID-19-Patients.html
https://www.globenewswire.com/news-release/2023/07/31/2714730/0/en/Bioxytran-Names-Leslie-Ajayi-as-Interim-CMO-and-Head-of-the-Medical-Advisory-Board.html
https://www.globenewswire.com/news-release/2023/06/27/2695160/0/en/Bioxytran-Peer-Reviewed-Journal-in-Vaccines-Contains-Mechanism-Capable-of-Targeting-Future-COVID-19-Mutations.html
https://www.globenewswire.com/news-release/2023/06/12/2686354/0/en/Bioxytran-Expands-Institutional-Investor-Base-with-an-additional-500-000-Equity-Investment.html
https://www.globenewswire.com/news-release/2023/05/01/2658256/0/en/Bioxytran-Interview-at-the-Emerging-Growth-Conference.html